SigTuple aims to create cloud-based solutions for detection of abnormalities and trends in medical data to improve the accuracy and efficiency of disease diagnosis
(L-R) SigTuple Co-founders Apurv Anand, Rohit Kumar Pandey, and Tathagato Rai Dastidar
SigTuple, a Bangalore-based healthcare technology startup, has secured US$5.8 million in Series A funding led by Accel Partners,with participation from IDG Ventures, Endiya Partners, and pi Ventures.
VH Capital and Axilor Partners, and other prominent investors, including Sachin Bansal and Binny Bansal (Co-founders of Flipkart), and Amit Singhal (SVP Engineering, Uber and Ex-SVP, Google Search), have also joined the round.
SigTuple will use the fresh capital to expand its team and bullet-proof its platform and the product for user adoption. SigTuple will also finance commercials and regulatory clearances for global markets.
Also Read: 4 ways mobile apps are transforming healthcare
The company had earlier raised US$740,000 in October 2015 from Sachin Bansal, Binny Bansal, Accel Partners, Ashok Bareja, Dr. Nirupa Bareja, and Debanjan Mukherjee.
SigTuple builds intelligent solutions for medical diagnosis using machine learning techniques. Its data-driven, cloud-based solutions are used to detect abnormalities and trends in medical data, which improves the accuracy and efficiency of disease diagnosis.
From crunching through microscopy images of blood to quantify normal and abnormal blood cells, to tracking sperm cells in microscopy videos, to localising pathologies in retinal scan images, SigTuple aims to make healthcare delivery affordable for all.
SigTuple microscope
SigTuple’s solutions allow labs and hospitals to scale by implementing a hub-and-spoke model, wherein the medical experts can operate from hub and devices can be installed in spokes.
The founders, Rohit Kumar Pandey, Apurv Anand, and Tathagato Rai Dastidar, are all technology industry veterans, with specialisation in Big Data, machine learning, image processing and building large scale enterprise platforms.
Also Read: I unleash my frustrations at the gym – Practo Co-founder and CEO Shashank ND
Kumar said: “Our goal is to develop intelligent, scalable and affordable disease screening solutions, which can empower medical experts and facilitate quality healthcare delivery to the masses. Our initial focus is on the solutions for the screening tests so that we can positively impact a larger population not only in India but globally.”
The company’s core product is Manthana, which allows SigTuple to ingest visual medical data from different devices and build a longitudinal memory. Currently, SigTuple is using Manthana to provide solutions for automated analysis of peripheral blood smear, urine and semen sample, retinal scans and chest x-rays.
SigTuple is working with large hospitals and labs and a group of medical experts in various fields to develop these solutions.
—-
The post Flipkart founders, Accel join medtech startup SigTuple’s US$5.8M funding appeared first on e27.